P25107 AF NFT

Parathyroid hormone/parathyroid hormone-related peptide receptor

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeigptjkm4c2mhcv2xwuqv4zqoyjhsgw2hvkuefn2qq7jxzevs5hmie/metadata.json
IPFS of structure file: 
bafybeidl3zdyhshxspqdvczpk6tcvmxqqne5gr6inhcxvdr2sa66y63nri/AF-P25107-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xb1c9f54629255bE8b3D28b82eAf097a839342609
First NFT owner address (bech32): 
genesis1k8yl233fy4d73v7j3wpw4uyh4qungfsf8nwtkt
Current NFT ID #318557 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
318557
Accession (UniProt):
P25107
Name::
Parathyroid hormone/parathyroid hormone-related peptide receptor
Experimental Method:
Predicted structure
Sequence source:
Didelphis virginiana

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT P25107 research and analysis (ICN3D with VR)

FASTA sequences

>sp|P25107|PTH1R_DIDVI Parathyroid hormone/parathyroid hormone-related peptide receptor OS=Didelphis virginiana OX=9267 GN=PTH1R PE=1 SV=2 MGAPRISHSLALLLCCSVLSSVYALVDADDVITKEEQIILLRNAQAQCEQRLKEVLRVPELAESAKDWMSRSAKTKKEKPAEKLYSQAEESREVSDRSRLQDGFCLPEWDNIVCWPAGVPGKVVAVPCPDYIYDFNHKGRAYRRCDSNGSWELVPGNNRTWANYSECVKFLTNETREREVFDRLGMIYTVGYSISLGSLTVAVLILGYFRRLHCTRNYIHMHLFVSFMLRAVSIFIKDAVLYSGVSTDEIERITEEELRAFTEPPPADKAGFVGCRVAVTVFLYFLTTNYYWILVEGLYLHSLIFMAFFSEKKYLWGFTLFGWGLPAVFVAVWVTVRATLANTECWDLSSGNKKWIIQVPILAAIVVNFILFINIIRVLATKLRETNAGRCDTRQQYRKLLKSTLVLMPLFGVHYIVFMATPYTEVSGILWQVQMHYEMLFNSFQGFFVAIIYCFCNGEVQAEIKKSWSRWTLALDFKRKARSGSSTYSYGPMVSHTSVTNVGPRGGLALSLSPRLAPGAGASANGHHQLPGYVKHGSISENSLPSSGPEPGTKDDGYLNGSGLYEPMVGEQPPPLLEEERETVM